HIV/AIDS-Associated Lipoatrophy
Lipoatrophic men 44 months post diagnosis less lipoatrophic, more hypertensive
Published in AIDS Weekly, September 19th, 2005
In a recently published study from Norway, investigators sought to "identify clinical factors associated with HIV-associated lipoatrophy and to evaluate body composition changes, blood pressure and lipid levels in lipoatrophic subjects 3-4 years after the atrophy diagnosis."
"Clinical signs of lipoatrophy were assessed in 308 ambulant HIV-positive patients in 2000-2001. Possible clinical risk factors, such as age, gender, race, wasting, duration of HIV infection, presence or absence of AIDS diagnosis, viral load and CD4 count, and detailed information about drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-09-19)
More Articles from AIDS Weekly
- HIV/AIDS Drug Development
Interferon-induced exonuclease ISG20 has antiviral activity against HIV-1 - HIV/AIDS Drug Development
Pertussis toxin b-oligomer inhibits HIV infection and replication - HIV/AIDS Exposure
Genotype associated with HIV-1-exposed but uninfected serostatus identified - HIV/AIDS Viremia
HIV RNA blips during HAART may reflect ongoing viremia which impair CD4 recovery - HIV/AIDS-Related Lypodystrophy
Recombinant growth hormone reduces visceral fat in HIV-related lipodystrophy - Aging
Further research needed on HIV in an aging population - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
